Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
N-Acetylcysteine for Drug-Induced Ototoxicity in Peritoneal Dialysis
NCT01131468Phase 2Completed
- Sponsor
- Erciyes University
- Start
- Feb 2008
- Primary completion
- Apr 2010
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, open-label trial of acetylcysteine in ototoxicity (2 arms), sponsored by Erciyes University. Primary endpoint: Pure Tone Audiometry at 12 months. Started Feb 2008; status: completed.
02
Drugs
acetylcysteine
03
Conditions
ototoxicity
Beyond the preview
Go deeper on NCT01131468.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01131468.